WHO IRIS >
Regional Office for Europe >
Technical documents >

Files in This Item:

File Description SizeFormat
Thumbnail
E60946.pdf894.76 kBAdobe PDFView/Open
Title: Access to drugs in the Newly Independent States : towards sharing the patient's burden : report on a WHO seminar, London, United Kingdom 13-14 October 1997
Authors: World Health Organization. Regional Office for Europe
Issue Date: 1998
Publisher: Copenhagen : WHO Regional Office for Europe
Language: English
Abstract: The WHO Regional Office for Europe organized a Seminar for the newly independent states (NIS) to analyse the increased cost of pharmaceuticals to patients and the effect of this on access to health care and to discuss successes and failures in the various countries. The aims of the seminar were to develop strategies and programmes aimed at providing political awareness of this problem, to suggest new approaches and concepts and to make policy-makers as well as government officials aware of the effect of their decisions on the accessibility, and especially the affordability, of health care and drug treatment for the entire population. The Seminar was attended by deputy ministers of health responsible for pharmaceuticals and heads of drug regulatory agencies. The Seminar provided an overview and basic information from the NIS on the role of national authorities, hospital managers, physicians and pharmacists in improving access to drugs in hospitals and primary health care. The Seminar provided participants with different mechanisms to increase access, such as improving methods of procurement, drug selection and prescribing, budgeting, drug reimbursement and regulatory measures. Examples of successful initiatives and approaches in different NIS were presented and discussed. As a result of the Seminar, the participants became more aware of the serious consequences of the declining affordability of drugs on the access to health care and its effect on the health of the population. The complex and political character of the problem is an additional hurdle in finding sustainable solutions. Practical and feasible recommendations were given, and the implementation of these recommendations at country and intercountry level will be followed up with the assistance of the pharmaceuticals programme
Description: EUR/ICP/QCPH 06 22 02(A)
English only
26 p.
Subject: Pharmaceutical Preparations
Drug Costs
Economics, Pharmaceutical
Essential drugs
Drug Utilization
Patient Advocacy
Health Services Accessibility
Commonwealth of Independent States
Context: supply and distribution
Gov't Doc #: EUR/ICP/QCPH 06 22 02(A)
URI: http://www.who.int/iris/handle/10665/107503
Appears in Collections:Technical documents



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.